Skip to main content
Fig. 2 | BMC Cancer

Fig. 2

From: LncRNA-PVT1 was identified as a key regulator for TMZ resistance and STAT-related pathway in glioma

Fig. 2

Landscape of clinical and molecular characteristics associated with PVT1 expression in gliomas. TCGA (A), CGGA (B) and GSE16011 (C) cohorts were arranged in an increasing order of PVT1 expression. The relationship between PVT1 expression and patients’ characteristics was evaluated. (a, the association between PVT1 and continuous variables was assessed using Pearson correlation tests. b, the distribution of PVT1 was assessed using the Student’s t test between two groups. c, the distribution of glioma purity between several groups was assessed using one-way ANOVA)

Back to article page